Arbutus Biopharma (ABUS) Intangibles (2009 - 2019)

Arbutus Biopharma's Intangibles history runs 7 years deep, the most recent figure standing at $43.8 million for Q2 2019.

• In Q2 2019, Intangibles fell 25.25% year-over-year to $43.8 million; the TTM figure through Jun 2019 stood at $43.8 million (down 25.25% YoY), while the FY2018 annual figure was $43.8 million, down 25.25% from the prior year.
• Intangibles came in at $43.8 million for Q2 2019 at Arbutus Biopharma, roughly flat from $43.8 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $390.0 million in Q2 2015 to a low of $43.8 million in Q3 2018.
• A 5-year average of $165.6 million and a median of $99.4 million in 2016 frame the typical range for Intangibles.
• On a YoY basis, Intangibles climbed as much as 9.5% in 2016 and fell as far as 71.8% in 2016.
• Arbutus Biopharma's Intangibles stood at $352.6 million in 2015, then slumped by 71.8% to $99.4 million in 2016, then slumped by 41.03% to $58.6 million in 2017, then fell by 25.25% to $43.8 million in 2018, then changed by 0.0% to $43.8 million in 2019.
• According to Business Quant data, Intangibles over the past three periods registered $43.8 million, $43.8 million, and $43.8 million for Q2 2019, Q1 2019, and Q4 2018 respectively.

Peer Comparison